Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:approvalYear |
2015
|
| gptkbp:approvedBy |
gptkb:European_Union
gptkb:United_States gptkb:FDA |
| gptkbp:ATCCode |
gptkb:V03AB35
|
| gptkbp:CASNumber |
343306-79-6
|
| gptkbp:chemicalFormula |
C72H104Na8O48S8
|
| gptkbp:developedBy |
gptkb:Organon
|
| gptkbp:genericName |
gptkb:sugammadex
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bridion
|
| gptkbp:indication |
reversal of muscle relaxation after surgery
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Merck_&_Co.
|
| gptkbp:mechanismOfAction |
encapsulates and inactivates neuromuscular blocking agents
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:PubChem_CID |
6918584
DB06720 |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
anaphylaxis
hypotension bradycardia |
| gptkbp:target |
gptkb:rocuronium
gptkb:vecuronium |
| gptkbp:UNII |
YOW8V9698H
|
| gptkbp:usedFor |
reversal of neuromuscular blockade
|
| gptkbp:bfsParent |
gptkb:Merck_&_Co.
|
| gptkbp:bfsLayer |
4
|